Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series
British Journal of Haematology · 2026-05 · 208 (5) · 1858-1862
DOI: 10.1111/bjh.70394 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 25.02.2026. Verfasst von Ekaterina Balaian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Department I, University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Department I, University Hospital Carl Gustav Carus Dresden, TU Dresden, Dresden, Germany.
- German Cancer Consortium (DKTK), Partner Site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- IMD Blood Coagulation Center, Bad Homburg, Germany.
ORCID-Profile: Ekaterina Balaian
Zitieren
APA
Balaian, E., Alesci, R. S., Marten, S., Georgi, J. A., Naue, C., Bornhäuser, M., & Trautmann-Grill, K. (2026). Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series. British Journal of Haematology, 208(5), 1858-1862. https://doi.org/10.1111/bjh.70394
Vancouver
Balaian E, Alesci RS, Marten S, Georgi JA, Naue C, Bornhäuser M, et al. Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series. British Journal of Haematology. 2026;208(5):1858-1862. doi:10.1111/bjh.70394
BibTeX
@article{Balaian2026,
author = {Balaian, Ekaterina and Alesci, Rosa Sonja and Marten, Sandra and Georgi, Julia-Annabell and Naue, Christiane and Bornhäuser, Martin and Trautmann-Grill, Karolin},
title = {Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {5},
pages = {1858--1862},
doi = {10.1111/bjh.70394}
}
EUVIMED